127 related articles for article (PubMed ID: 11013662)
1. The costs of managing patients with malignant glioma at a neuro-oncology clinic.
Latif AZ; Signorini D; Gregor A; Whittle IR
Br J Neurosurg; 1998 Apr; 12(2):118-22. PubMed ID: 11013662
[TBL] [Abstract][Full Text] [Related]
2. Application of the MRC brain tumour prognostic index to patients with malignant glioma not managed in randomised control trial.
Latif AZ; Signorini D; Gregor A; Grant R; Ironside JW; Whittle IR
J Neurol Neurosurg Psychiatry; 1998 Jun; 64(6):747-50. PubMed ID: 9647303
[TBL] [Abstract][Full Text] [Related]
3. A pilot cost-effectiveness analysis of treatments in newly diagnosed high-grade gliomas: the example of 5-aminolevulinic Acid compared with white-light surgery.
Esteves S; Alves M; Castel-Branco M; Stummer W
Neurosurgery; 2015 May; 76(5):552-62; discussion 562. PubMed ID: 25714513
[TBL] [Abstract][Full Text] [Related]
4. Assessing the total costs of blood delivery to hospital oncology and haematology patients.
Agrawal S; Davidson N; Walker M; Gibson S; Lim C; Morgan CL; Cowell W
Curr Med Res Opin; 2006 Oct; 22(10):1903-9. PubMed ID: 17022848
[TBL] [Abstract][Full Text] [Related]
5. Economics of Malignant Gliomas: A Critical Review.
Raizer JJ; Fitzner KA; Jacobs DI; Bennett CL; Liebling DB; Luu TH; Trifilio SM; Grimm SA; Fisher MJ; Haleem MS; Ray PS; McKoy JM; DeBoer R; Tulas KM; Deeb M; McKoy JM
J Oncol Pract; 2015 Jan; 11(1):e59-65. PubMed ID: 25466707
[TBL] [Abstract][Full Text] [Related]
6. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
7. Management of patients aged >60 years with malignant glioma: good clinical status and radiotherapy determine outcome.
Whittle IR; Basu N; Grant R; Walker M; Gregor A
Br J Neurosurg; 2002 Aug; 16(4):343-7. PubMed ID: 12389886
[TBL] [Abstract][Full Text] [Related]
8. Direct medical costs of treatment in newly-diagnosed high-grade glioma among commercially insured US patients.
Jiang S; Hill K; Patel D; Waldeck AR; Botteman M; Aly A; Norden AD
J Med Econ; 2017 Dec; 20(12):1237-1243. PubMed ID: 28777020
[TBL] [Abstract][Full Text] [Related]
9. Steps towards cost-benefit analysis of regional neurosurgical care.
Pickard JD; Bailey S; Sanderson H; Rees M; Garfield JS
BMJ; 1990 Sep; 301(6753):629-35. PubMed ID: 2121302
[TBL] [Abstract][Full Text] [Related]
10. Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma.
Weller M; Müller B; Koch R; Bamberg M; Krauseneck P;
J Clin Oncol; 2003 Sep; 21(17):3276-84. PubMed ID: 12947063
[TBL] [Abstract][Full Text] [Related]
11. Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
Wasserfallen JB; Ostermann S; Leyvraz S; Stupp R
Neuro Oncol; 2005 Apr; 7(2):189-95. PubMed ID: 15831237
[TBL] [Abstract][Full Text] [Related]
12. Validation of the Medical Research Council and a newly developed prognostic index in patients with malignant glioma: how useful are prognostic indices in routine clinical practice?
Akman F; Cooper RA; Sen M; Tanriver Y; Kentli S
J Neurooncol; 2002 Aug; 59(1):39-47. PubMed ID: 12222837
[TBL] [Abstract][Full Text] [Related]
13. The use and cost of hospital services by London AIDS patients with different AIDS defining conditions.
Beck EJ; Kupek EJ; Wadsworth J; Miller DL; Pinching AJ; Harris JR
J Public Health Med; 1996 Dec; 18(4):457-64. PubMed ID: 9023806
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of topotecan for small cell lung cancer: a systematic review and economic evaluation.
Loveman E; Jones J; Hartwell D; Bird A; Harris P; Welch K; Clegg A
Health Technol Assess; 2010 Mar; 14(19):1-204. PubMed ID: 20356561
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of a general practitioner with special interests led dermatology service in primary care.
Coast J; Noble S; Noble A; Horrocks S; Asim O; Peters TJ; Salisbury C
BMJ; 2005 Dec; 331(7530):1444-9. PubMed ID: 16339217
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of a malignant glioma protocol.
Konski A; Bracy P; Weiss S; Grigsby P
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):575-8. PubMed ID: 9336135
[TBL] [Abstract][Full Text] [Related]
17. A cost analysis of monoplace hyperbaric oxygen therapy with and without recirculation.
Treweek S; James PB
J Wound Care; 2006 Jun; 15(6):235-8. PubMed ID: 16802558
[TBL] [Abstract][Full Text] [Related]
18. Is day care equivalent to inpatient care for active rheumatoid arthritis? Randomised controlled clinical and economic evaluation.
Lambert CM; Hurst NP; Forbes JF; Lochhead A; Macleod M; Nuki G
BMJ; 1998 Mar; 316(7136):965-9. PubMed ID: 9550954
[TBL] [Abstract][Full Text] [Related]
19. Treatment by specialist surgical neurooncologists improves survival times for patients with malignant glioma.
Khan UA; Bhavsar A; Asif H; Karabatsou K; Leggate JR; Sofat A; Kamaly-Asl ID
J Neurosurg; 2015 Feb; 122(2):297-302. PubMed ID: 25415070
[TBL] [Abstract][Full Text] [Related]
20. Hospital resources consumed for surgical morbidity: effects of preoperative arginine and omega-3 fatty acid supplementation on costs.
Braga M; Gianotti L; Vignali A; Schmid A; Nespoli L; Di Carlo V
Nutrition; 2005; 21(11-12):1078-86. PubMed ID: 16308130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
